Arthritis and Osteoporosis: 2006 Trends & Treatments
Arthritis and Osteoporosis: 2006 Trends & Treatments
www.researchandmarkets.com
ChangeWave, Feb 2006, Pages: 19
During January 13 and 14, 2006 we conducted an Alliance survey on Arthritis and Osteoporosis. A total of 67 doctors who are involved in - or who work in a practice involved in - the diagnosis or treatment of Arthritis and Osteoporosis participated.
Questions Answered in this Report:
- Is the typical new Osteoarthritis patient younger, older, or about the same age when compared to the historical norm?
- Is the typical new Osteoarthritis patient coming in earlier, later, or at the same stage of the disease when compared to the historical norm?
- What is the most common first-line treatment prescribed or recommended for mild, moderate, and advanced symptoms of osteoarthritis?
- What is the most promising new treatment on the horizon for the treatment of osteoarthritis?
- What is the most common treatment for Rheumatoid Arthritis (RA) patients?
- Are Doctors likely to recommend Orencia for Rheumatoid Arthritis?
- Which surgical procedures are Doctors most likely to perform or recommend over the next 12 months?
- Who is the top vendor for joint replacement products?
- What is the most recommended bone density test?
- What overall effect has the Cox-II Inhibitor problem had on Merck and Pfizer?
Reasons to purchase this report:
- Find out the most common treatments for Osteoarthritis
- Discover the top treatments for Rheumatoid Arthritis
- Identify the most prescribed treatment for Osteoporosis
- Understand the impact of Cox II Inhibitor problems on Merck and Pfizer
Customers who bought this item also bought
Rheumatoid Arthritis Drug Discoveries: What The Future Holds
Commercial Insight: Osteoarthritis and Rheumatoid Arthritis - New Growth In A Mature Market
Treatment Algorithms: Rheumatoid Arthritis 2nd Edition - Dmards Move to Front of Pack
Osteoarthritis and Rheumatoid Arthritis: Opinion Leader Forum - Expert's Views and Perspectives on Diagnosis, Treatment, Product Performance and Closing the Need Gap
Arthritis in the United States
Pipeline Insight: Disease Modification In Rheumatoid Arthritis - Competition For The Anti-TNF Failure Patient Population Increases
Stakeholder Insight: Rheumatoid Arthritis - Biologics Battle Up the Treatment Algorithm
Pipeline Insight: Rheumatoid Arthritis and Osteoarthritis - Striving for innovation among me-toos
Rheumatoid Arthritis: Market Trends and R&D Insights
Therapeutic Clinical Intelligence - Rheumatoid Arthritis - 2009 Edition
Osteoarthritis - Preconceptions Damage Awareness and Treatments
Autoimmune And Inflammation Rheumatoid Arthritis
All rights reserved. © Copyright 2009 Research and Markets
Votes:36
Comments: 0